Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Stock Issued During Period, Shares, New Issues

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Stock Issued During Period, Shares, New Issues of 3.58 million shares for the 9-month period ending 2023-12-31, per its 10-Q filed 2024-02-13.

Discontinued › Shareholders' Equity

us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-02-13

  • 2023-12-31: Stock Issued During Period, Shares, New Issues 9 month 3.58M shares.
  • 2020-12-31: Stock Issued During Period, Shares, New Issues 63.00M shares.
  • 2020-08-31: Stock Issued During Period, Shares, New Issues 15.63M shares.
Period endStock Issued During Period, Shares, New IssuesStock Issued During Period, Shares, New Issues 9 month
2023-12-313.58M shares
10-Q · filed 2024-02-13
2020-12-3163.00M shares
10-K · filed 2022-06-23
2020-08-3115.63M shares
10-K · filed 2022-06-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B